Allied Health Professionals

logo February 2012
60 Murray Street 3rd Floor
Toronto Ontario M5T 3L9
1-877-586-5112
www.zanecohencentre.ca
 imgbar
NEW WEBSITE - A VALUABLE DIGESTIVE DISEASES RESOURCE

Dear friends,

Fulfilling our commitment to providing support and education to clinicians, patients and their care takers, we are very proud to announce the launch of the new website for Zane Cohen Centre for Digestive Diseases

webpageA visit to this website offers you a diverse array of resources, reflecting current breakthrough work in Gastrointestinal Cancers and Inflammatory Bowel Diseases research, carried out by one of the best interdisciplinary teams in the world.

You can access the website directly through http://www.zanecohencentre.ca

As you navigate through the website, please note just a few of our new features:

  • News and events scrolling with auto update
  • User friendly menus for easy navigation
  • ZCCTube – how cool!
  • Enhanced staff profile and contact pages
  • Convenient shortcuts to research sections
  • Donor directed donation links

 

On behalf of the Zane Cohen Centre staff,

Best Wishes

Dr. Zane Cohen

 a

We are pleased to keep you informed about our work. If you do not wish to receive
future e-newsletter publications, click here
.

Questions or comments? E-mail us at zcc@mtsinai.on.ca   call us at 1-877-586-5112
logo March 2012
60 Murray Street 3rd Floor
Toronto Ontario M5T 3L9
1-877-586-5112
www.zanecohencentre.ca
 FAMILIAL GASTROINTESTINAL CANCER REGISTRY
N E W   W E B S I T E   L A U N C H E D - A   V A L U A B L E    R E S O U R C E

Dear friends,

 

Fulfilling our commitment to providing support and education to clinicians, patients and their care takers, we are very proud to announce the launch of the new website for Zane Cohen Centre for Digestive Diseases.

A visit to this website offers you a wide range of resources, reflecting current breakthrough work in Gastrointestinal Cancers carried out by one of the best interdisciplinary teams in the world.

Right from the home page, you can easily navigate to the FGICR, find information about particular diseases, and get updates from the research teams.

We have a number of new features, including the ZCCTube, with an informative video on the work of the FGICR team, and some patient profiles for FAP and Lynch Syndrome. http://www.zanecohencentre.ca/zcc-tube.

Also, please note

  • The news events scrolling with auto update
  • User friendly menus for easy navigation
  • Staff profile pages
  • Contact Us, Directions and Maps
  • Donor directed donation links

You can access the website directly through http://www.zanecohencentre.ca or http://www.zanecohencentre.com.

We look forward to your feedback: tberk@mtsinai.on.ca

Best Wishes from the FGICR team


Terri Berk, Clinical Co-ordinator
Melyssa Aronson, Senior Genetic Counsellor
Kara Semotiuk, Genetic Counsellor
Spring Holter, Genetic Counsellor
Jennifer La, Administrative Assistant
Rosella Panarisi, Data Analyst


webpage

We are pleased to keep you informed about our work. If you do not wish to receive
future e-newsletter publications, click here
.

Questions or comments? E-mail us at zcc@mtsinai.on.ca   call us at 1-877-586-5112

E-newsletter of Zane Cohen Centre for Digestive Diseases - April 2014

logo April 17th, 2014
60 Murray Street 3rd Floor
Toronto Ontario M5T 3L9
1-877-586-5112
www.zanecohencentre.ca
ZANE COHEN CENTRE FOR DIGESTIVE DISEASES
April 2014 Update

AN INVITATION FROM DR. ZANE COHEN, DIRECTOR

 
 zcohen

"We build knowledge to improve treatment” has been our motto of our translational research centre from day one. We continue to be proud of our collaborative team structure consisting of gastroenterologists, surgeons, scientists, psychologists, pathologists, molecular geneticists, genetic counsellors and information technologists focusing on causes of hereditary cancers and inflammatory bowel diseases.

It is because our investigators are also clinicians, that we have the ability, to quickly and effectively bring new research findings into reality with more tailored and efficient treatment and patient care. We invite you to take advantage of resources offered in this newsletter.

GASTROINTESTINAL CANCERS

 


Familial Gastrointestinal Cancer Registry (FGICR)

  • The FGICR continues to grow with over 2,500 individuals in our Registry. Research continues to look at the hereditary cancer risk and prevention, as well as discovering new genes to explain colorectal polyps and GI cancer in all high-risk families. read more

  • Join us in welcoming our newest Genetic Counsellor, Laura Winter. She will work alongside Melyssa Aronson, Kara Semotiuk and Spring Holter. read more

  • We would like to thank Terri Berk for her 30 years of service and wish her a happy retirement.


Canadian Colorectal Cancer Consortium (C4)

TFRI C4 Logo

  • We are pleased to announce that the launch of the Canadian Colorectal Cancer Consortium (C4) since October 2013. read more


Ontario Pancreas Cancer Study (OPCS)

  • Recruitment is proceeding well. Patients and families are happy to be able to take part in our research. We are involved in several collaborations with international, domestic and local investigators and papers have been published using data from the registry. read more


Ontario Familial Colorectal Cancer Registry (OFCCR)

  • Dr. Tae Hart is currently collecting data from participants in the Ontario Familial Colorectal Cancer Registry to examine symptom management problems and quality of life in people who were diagnosed with colorectal cancer more than ten years ago. This study is currently funded by the Canadian Institute of Health Research. read more


Canadian Partnership Against Cancer (CPAC) Rectal Cancer Project

  • PI: Erin Kennedy

  • Co-PIs: Robin McLeod, Nancy Baxter, Marko Simunovic

  • Funding Awarded: $903 000
  • We would like to congratulate Dr. Erin Kennedy on the funding awarded to the Canadian Partnership Against Cancer (CPAC) Rectal Cancer Project that she will be spearheading it along with Dr. Robin McLeod. The CPAC Rectal Cancer Project is a multi-year project designed to improve the clinical outcomes for patients by implementing quality initiatives for rectal cancer across Canada.  These quality initiatives include (i) pre-operative staging using magnetic resonance image (MRI), (ii) multidisciplinary cancer conference (MCC), (iii)TME surgery and (iv) pathologic assessment using the Quirke method.    The implementation of these quality initiatives will be evaluated using a set of quality indicators developed for the study and reporting the degree to which each of these quality indicators is achieved at regular intervals on both a national and institutional level.  Additional site specific knowledge translation strategies will be used to further enhance the implementation of these quality initiatives at each individual centre.  This project is highly relevant as successful wide spread implementation of these quality initiatives will lead to improved and more standardized rectal cancer care and set a national standard for these quality initiatives across Canada.

FAP Study at Mount Sinai Hospital

  • Cancer Prevention Pharmaceuticals recently opened a clinical trial, at the Zane Cohen Centre, evaluating a new drug combination for patients with Familial Adenomatous Polyposis (FAP). This study will determine if a combination drug treatment can work better than each drug alone in preventing the disease from getting worse. read more

  • The purpose of this randomized, double-blind, Phase III trial is to determine if the combination of eflornithine plus sulindac is superior to sulindac or eflornithine as single agents in delaying time to the first occurrence of any FAP-related event. This includes: 1) FAP related disease progression indicating the need for excisional intervention involving the colon, rectum, pouch, duodenum and/or 2) clinically important events which includes progression to more advanced duodenal polyposis, cancer or death.

  • More information can be obtained by visiting: ClinicalTrials.gov and search for study NCTO1483144 or visit www.canprevent.com.

INFLAMMATORY BOWEL DISEASE

 


IBD Research

  • Since 2003, Dr. Silverberg’s IBD genetics and biomarkers research studies have included more than 6,000 participants. These studies have contributed to finding over 160 single nucleotide polymorphisms (SNPs), which are genetic markers associated with IBD.

  • The role of the microbiome (gut bacteria) is actively being studied by Dr. Silverberg’s research group. Of particular interest is the impact of diet on the microbiome of individuals with IBD. Preliminary findings, in ulcerative colitis patients who’ve undergone an ileal pouch anal anastomosis (pelvic pouch), show that several groups of organisms are associated with pelvic pouch inflammation, with notable decreases in several bacteria with anti-inflammatory potential detected in individuals with inflammation. Of particular interest is the impact of diet on the microbiome in individuals both with and without IBD.

  • In addition, Dr. Silverberg’s research group initiated a study investigating recurrence of inflammation in CD patients undergoing their first ileal resection surgery. This study has now been implemented in other North American centres as part of the NIH/NIDDK IBD Genetics Consortium.

  • We are currently gearing up for Digestive Disease Week, an annual conference, being held in Chicago in early May. We have a large number of abstracts accepted to this international conference and are looking forward to sharing our research findings with physicians and researchers from around the world.

  • For more information on how to get involved in our research studies, please go to our website: http://www.zanecohencentre.com/ibd/research


gem

  • Crohn’s and Colitis Canada and the Leona M. and Harry B. Helmsley Charitable Trust today announced the largest-ever funding commitment to Crohn’s disease research in Canada.  The funds will support the Genetics, Environmental, Microbial (GEM) Project, a Canadian-led international research study investigating the causes of Crohn’s disease.

  • The $10 million funding commitment is made possible by a lead gift of $6 million from the Helmsley Charitable Trust, one of the largest family trusts in the United States, which includes a focus on Crohn’s disease amongst its funding priorities. The Helmsley Charitable Trust grant will be matched by a further $4 million in active fundraising from Crohn’s and Colitis Canada.

  • Canadians have more reasons to be concerned about Crohn’s disease than anyone else in the world.  Canada has one of the highest rates worldwide. An estimated 130,000 Canadians have this lifelong disease. Most alarming, the number of new cases of Crohn’s disease in Canadian children has almost doubled since 1995.

  • The GEM Project investigates the ways in which genetic predisposition, environmental influences and microbial interactions combine to determine if a person develops Crohn’s disease. To do this, researchers study healthy relatives – either siblings or children of people living with Crohn’s disease. To-date, the GEM Project has recruited more than 2,800 participants. The aim of the increased funding is to reach 5,000 recruits and the project is actively recruiting eligible participants.

  • To participate in or learn more about the GEM Project, please visit www.gemproject.ca

IBD Centre of Excellence

  • We are happy to report on continuation and expansion of the well-received IBDWell patient education and self-management program. read more

  • Work is being done in the area of pediatric to adult transitioning of IBD patients via the Transition Clinic between SickKids and MSH and the IMPACT-IBD study of transition care being carried out by Geoff Nguyen and one of our new IBD Fellows – Natasha Bollegala.

 

SURGICAL PROGRAMS

 


Best Practice in General Surgery (BPIGS)

  • The BPIGS group is currently developing guidelines for Diverticulitis, Pancreatitis, Bariatric Surgery-VTE prophylaxis, and Blood Conservation. read more


Implementation of Enhanced Recovery after Surgery (iERAS)

  • The BPIGS group received a grant from the Council of Academic Hospitals of Ontario (CAHO) to implement our Enhanced Recovery After Surgery (ERAS) program at 15 centres across the province. read more

  • We currently have data on over 1000 patients accruing approx. 50 patients per week, and our patient satisfaction survey has shown excellent results. read more

WE INVITE YOU TO PARTNER WITH US

 


Our researchers are clinicians, quickly bringing new findings into their practices, thereby saving and enhancing the quality of patients’ lives. 

You may not know that this breakthrough research is funded in large part by grateful patient donors.

Please contact Patricia Tolkin Eppel, Advancement Director, Mount Sinai Foundation,
to learn about the many ways you can partner with us:

Email: ptolkineppel@mtsinai.on.ca
Tel: 416 586-4800 #2956.

I look forward to chatting with you
If you wish to donate online, click here

Donate

 
 

We are pleased to keep you informed about our work. If you do not wish to receive
future e-newsletter publications, click here
.

Questions or comments? E-mail us at zcc@mtsinai.on.ca   call us at 1-877-586-5112
WE INVITE YOU TO PARTNER WITH US TODAY
Donate to the Zane Cohen Centre
Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Joseph and Wolf Lebovic Health Complex. Copyright © 1997 - 2017.
All Rights Reserved. A patient care, teaching and research centre affiliated with University of Toronto.
Powered by Joomla 1.7 Templates